Quinacrine Has Preferential Anticancer Effects on Mesothelioma Cells With Inactivating NF2 Mutations
Mesothelioma is a rare cancer with disproportionately higher death rates for shipping and mining populations. These patients have few treatment options, which can be partially attributed to limited chemotherapy responses for tumors. We initially hypothesized that quinacrine could be combined with ci...
Main Authors: | Derek B. Oien, Sayantani Sarkar Bhattacharya, Jeremy Chien, Julian Molina, Viji Shridhar |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.750352/full |
Similar Items
-
Repurposing Quinacrine for Treatment of Malignant Mesothelioma: In-Vitro Therapeutic and Mechanistic Evaluation
by: Nishant S. Kulkarni, et al.
Published: (2020-08-01) -
CHARACTERIZATION OF VR118 QUINACRINE DERIVATIVE AS A POTENTIAL ANTICANCER AGENT
by: Almnayan, Danah
Published: (2014) -
Quinacrine Induces Nucleolar Stress in Treatment-Refractory Ovarian Cancer Cell Lines
by: Derek B. Oien, et al.
Published: (2021-09-01) -
Dropwort-induced metabolic reprogramming restrains YAP/TAZ/TEAD oncogenic axis in mesothelioma
by: Claudio Pulito, et al.
Published: (2019-08-01) -
NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma
by: Tatsuhiro Sato, et al.
Published: (2018-03-01)